D-0150-2018 Class I Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-0150-2018 was initiated by Pfizer Inc. on Oct 20, 2017 and is designated Class I. Reason for recall: SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent The recall status is terminated (terminated Jun 2, 2020). Affected quantity: 183437 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 10, 2018
Initiation Date
Oct 20, 2017
Termination Date
Jun 2, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
183437 bottles

Product description

diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC. Peapack, NJ 07977

Reason for recall

SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent

Distribution pattern

Nationwide in the USA

Code information

Lots: a) R83962, R93347, R93348, R93349, R93350, R93351, R93352, Exp. 2021 OCT 31; S57831, S57832, S57834, Exp. 2021 NOV 30 b) R93356, R93357, R93358, R97310, Exp. 2021 OCT 31.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0150-2018
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0150-2018. Report a data issue: hello@regdatalab.com.